Merck (MRK) Prepaid Assets (2009 - 2026)
Merck (MRK) reported Prepaid Assets of $10.6 billion for Q1 2026, up 14.37% year-over-year from $9.3 billion in Q1 2025, and up 1.01% quarter-over-quarter from $10.5 billion in Q4 2025.
Merck (MRK) Prepaid Assets (2009 - 2026) Analysis & Trends
Merck (MRK) has 16 years of Prepaid Assets data on file, last reported at $10.6 billion in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $10.6 billion, up 14.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.6 billion (up 14.37% YoY), and the FY2025 annual result was $10.5 billion, up 20.81% from the prior year.
- Prepaid Assets rose to $10.6 billion in Q1 2026 per MRK's latest filing, from $10.5 billion in the prior quarter.
- Over five years, Prepaid Assets peaked at $10.8 billion in Q3 2025 and troughed at $6.7 billion in Q3 2023.
- A 5-year average of $8.9 billion and a median of $8.7 billion in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets advanced 2.6% in 2022, then jumped 32.37% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $7.2 billion in 2022, then rose by 16.72% to $8.4 billion in 2023, then rose by 4.04% to $8.7 billion in 2024, then increased by 20.81% to $10.5 billion in 2025, then grew by 1.01% to $10.6 billion in 2026.
- Business Quant data shows MRK's Prepaid Assets at $10.6 billion in Q1 2026, $10.5 billion in Q4 2025, and $10.8 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.62 Bn |
| Dec 31, 2025 | 10.52 Bn |
| Sep 30, 2025 | 10.78 Bn |
| Jun 30, 2025 | 10.00 Bn |
| Mar 31, 2025 | 9.29 Bn |
| Dec 31, 2024 | 8.71 Bn |
| Sep 30, 2024 | 8.14 Bn |
| Jun 30, 2024 | 8.74 Bn |
| Mar 31, 2024 | 7.95 Bn |
| Dec 31, 2023 | 8.37 Bn |
| Sep 30, 2023 | 6.66 Bn |
| Dec 31, 2022 | 7.17 Bn |
| Dec 31, 2021 | 6.99 Bn |
| Dec 31, 2020 | 4.67 Bn |
| Dec 31, 2019 | 4.28 Bn |
| Dec 31, 2018 | 4.50 Bn |
| Dec 31, 2017 | 4.30 Bn |
| Dec 31, 2016 | 4.39 Bn |
| Dec 31, 2015 | 5.14 Bn |
| Dec 31, 2014 | 4.69 Bn |